The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Instotal     10-(1-azabicyclo[2.2.2]oct- 8...

Synonyms: Primalan, Virginan, Kitazemin, Vigigan, Zesulan, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Instotal

 

Psychiatry related information on Instotal

  • Divided attention performance was also affected by Treatment. Reaction time (RT) during mequitazine treatments increased in a dose-related manner and significantly differed from placebo at the highest dose [6].
  • OBJECTIVE: The present study compares the sedative effects of three doses of mequitazine on actual driving, psychomotor performance and memory with those of a first- and a second-generation antihistamine [6].
 

High impact information on Instotal

 

Chemical compound and disease context of Instotal

 

Biological context of Instotal

 

Anatomical context of Instotal

 

Associations of Instotal with other chemical compounds

 

Analytical, diagnostic and therapeutic context of Instotal

  • The first procedure is based on determination of mequitazine by HPLC with UV detection at 256 nm [28].
  • The results suggested that after the oral administration only low mequitazine concentrations appeared in serum, most of the drug seemed to be deactivated by the extrarenal route, and the kinetic properties of the drug resembled those of several phenothiazines used for psychiatric therapy [29].
  • In order to achieve a better tolerance, patients are protected with antihistamines on the days they are administered the immunotherapy (mequitazine 5 mg every 12 hours) and also, doses equal or over 40 micrograms are given fractionally, injecting half dose in each arm [30].
  • The suppressive activity of mequitazine (MQZ) on histamine skin reactivity was evaluated in 29 healthy subjects (age 22-25 years) in a single-blind study [31].
  • Determination of mequitazine in human plasma by gas-chromatography/mass spectrometry with ion-trap detector and its pharmacokinetics after oral administration to volunteers [19].

References

  1. Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Haria, M., Fitton, A., Peters, D.H. Drugs (1994) [Pubmed]
  2. Efficacy of mequitazine in comparison with placebo assessed by ocular challenge with allergen in allergic conjunctivitis. Persi, L., Dupin, O., Arnaud, B., Trinquand, C., Michel, F.B., Bousquet, J. Allergy (1997) [Pubmed]
  3. Evaluation of the antimuscarinic activity of atropine, terfenadine and mequitazine in healthy volunteers. Brion, N., Beaumont, D., Advenier, C. British journal of clinical pharmacology. (1988) [Pubmed]
  4. Autonomic dysfunction in perennial vasomotor rhinitis and the effect of mequitazine. Mayeux, D., Le Van, D., Pitois, M., Rivasseau, J., Kohler, C., Grilliat, J.P. Current medical research and opinion. (1986) [Pubmed]
  5. Mequitazine in the treatment of hayfever. Beaumont, G., Dobbins, S., Latta, D., McMillin, W.P. The British journal of clinical practice. (1990) [Pubmed]
  6. A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo. Theunissen, E.L., Vermeeren, A., van Oers, A.C., van Maris, I., Ramaekers, J.G. Clin. Exp. Allergy (2004) [Pubmed]
  7. Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis. Skassa-Brociek, W., Bousquet, J., Montes, F., Verdier, M., Schwab, D., Lherminier, M., Michel, F.B. J. Allergy Clin. Immunol. (1988) [Pubmed]
  8. The histamine H1-receptor antagonist binding site. A stereoselective pharmacophoric model based upon (semi-)rigid H1-antagonists and including a known interaction site on the receptor. ter Laak, A.M., Venhorst, J., Donné-Op den Kelder, G.M., Timmerman, H. J. Med. Chem. (1995) [Pubmed]
  9. Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes. Nakamura, K., Yokoi, T., Kodama, T., Inoue, K., Nagashima, K., Shimada, N., Shimizu, T., Kamataki, T. J. Pharmacol. Exp. Ther. (1998) [Pubmed]
  10. Cholinergic and H1-receptor influences of histamine on slowly adapting pulmonary stretch receptor activity in the rabbit. Matsumoto, S., Nagayama, T., Yamasaki, M., Kanno, T., Shimizu, T. J. Auton. Nerv. Syst. (1992) [Pubmed]
  11. Randomised double masked trial comparing the efficacy and tolerance of 0.05% mequitazine eye drops versus 0.05% levocabastine and placebo in allergic conjunctivitis induced by a conjunctival provocation test with Dermatophagoides pteronyssinus. Mortemousque, B., Jacquet, A., Richard, C., Depont, F., Colin, J., Moore, N. The British journal of ophthalmology. (2004) [Pubmed]
  12. A double-blind comparison of terfenadine and mequitazine in the symptomatic treatment of acute pollinosis. Hugonot, L., Hugonot, R., Beaumont, D. J. Int. Med. Res. (1986) [Pubmed]
  13. Mequitazine and dexchlorpheniramine in perennial rhinitis. A double-blind cross-over placebo-controlled study. Pukander, J.S., Karma, P.H., Penttilä, M.A., Perälä, M.E., Ylitalo, P., Kataja, M.J. Rhinology. (1990) [Pubmed]
  14. A comparison of topical mequitazine and disodium cromoglycate in allergic conjunctivitis induced by a specific conjunctival provocation test. Dupin, O., Trinquand, C., Persi, L., Bousquet, J., Robert, F., Arnaud, B. European journal of ophthalmology. (2000) [Pubmed]
  15. Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine. Demaubeuge, J., Tennstedt, D., Broux, R. Dermatologica (1982) [Pubmed]
  16. Ketoconazole potentiates terfenadine-induced apoptosis in human Hep G2 cells through inhibition of cytochrome p450 3A4 activity. Wang, Y.J., Yu, C.F., Chen, L.C., Chen, C.H., Lin, J.K., Liang, Y.C., Lin, C.H., Lin, S.Y., Chen, C.F., Ho, Y.S. J. Cell. Biochem. (2002) [Pubmed]
  17. Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients. Hasegawa, T., Takagi, K., Kuzuya, T., Nadai, M., Apichartpichean, R., Muraoka, I. Eur. J. Clin. Pharmacol. (1990) [Pubmed]
  18. The H1-antagonist mequitazine: studies on performance and visual function. Nicholson, A.N., Stone, B.M. Eur. J. Clin. Pharmacol. (1983) [Pubmed]
  19. Determination of mequitazine in human plasma by gas-chromatography/mass spectrometry with ion-trap detector and its pharmacokinetics after oral administration to volunteers. Kwon, O.S., Kim, H.J., Pyo, H., Chung, S.J., Chung, Y.B. Arch. Pharm. Res. (2005) [Pubmed]
  20. The interaction of mequitazine with phospholipid model membranes. Ahmed, M., Hadgraft, J., Burton, J.S., Kellaway, I.W. Chem. Phys. Lipids (1980) [Pubmed]
  21. Possible mechanisms of vasoinhibitory effects of mequitazine, an antiallergic agent, on the contractions of isolated rat aorta induced by K+, phenylephrine, 5-hydroxytryptamine, and Ca2+. Satake, N., Zhou, Q., Shibata, S. J. Cardiovasc. Pharmacol. (1994) [Pubmed]
  22. Inhibitory effect of epinastine on superoxide generation by rat neutrophils. Fukuishi, N., Kan, T., Hirose, K., Akagi, R., Akagi, M. Jpn. J. Pharmacol. (1995) [Pubmed]
  23. Effects of nonsedating histamine H1-antagonists on EEG activity and behavior in the cat. Marzanatti, M., Monopoli, A., Trampus, M., Ongini, E. Pharmacol. Biochem. Behav. (1989) [Pubmed]
  24. Antihistaminic and anticholinergic activities of mequitazine in comparison with clemizole. Martinez-Mir, I., Estañ, L., Rubio, E., Morales-Olivas, F.J. J. Pharm. Pharmacol. (1988) [Pubmed]
  25. Effects of two antihistaminic compounds (mequitazine, dexchlorpheniramine) on sleep. Sleep distorsion by antihistaminics. Bassano, J.L., Caille, E.J. Waking and sleeping. (1979) [Pubmed]
  26. A method for evaluating anti-allergic drugs by simultaneously induced passive cutaneous anaphylaxis and mediator cutaneous reactions. Koda, A., Miura, T., Inagaki, N., Sakamoto, O., Arimura, A., Nagai, H., Mori, H. Int. Arch. Allergy Appl. Immunol. (1990) [Pubmed]
  27. Bronchodilating activity of mequitazine. Rossoni, G., Omini, C., Folco, G.C., Vigano, T., Brunelli, G., Berti, F. Archives internationales de pharmacodynamie et de thérapie. (1984) [Pubmed]
  28. Stability indicating methods for assay of mequitazine in presence of its degradate. El-Ragehy, N.A., Badawey, A.M., El Khateeb, S.Z. Journal of pharmaceutical and biomedical analysis. (2002) [Pubmed]
  29. Serum levels and urinary excretion of mequitazine after a single oral dose. Ylitalo, P., Nieminen, K., Wilén-Rosenqvist, G., Fourtillan, J.B., Girault, J., Ylitalo, L., Pukander, J.S., Karma, P.H. International journal of clinical pharmacology research. (1989) [Pubmed]
  30. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy. Díez Gómez, M.L., Quirce Gancedo, S., Juliá de Páramo, B. Allergologia et immunopathologia. (1995) [Pubmed]
  31. Suppressive effects of histamine skin reactivity by a nonsedating antihistamine-mequitazine. Vichyanond, P., Jongpanichkultorn, S., Aranyanark, N., Tuchinda, M. Asian Pac. J. Allergy Immunol. (1991) [Pubmed]
 
WikiGenes - Universities